ArticleAging clinical and experimental research2025
Machine learning-based online web calculator predicts the risk of sarcopenic obesity in older adults.
Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Sleeve Gastrectomy Effect on Structural and Functional Myocardium Characteristics and Trpc3, Trpc6, Tgfb1, and Atp2a2 Gene Expression in Rats with Post-Infarction Heart Failure.Bulletin of experimental biology and medicine · 2026Article
- Sarcopenia and MASLD: novel insights and the future.Nature reviews. Endocrinology · 2026Review
- Comparative analysis of sarcopenic obesity detection and associated mental-cognitive outcomes in community-dwelling older adults: impact of using body mass index versus waist circumference.BMC geriatrics · 2026Article
- A LASSO-based nomogram for predicting sarcopenia-related nutritional risk in esophageal cancer patients: model development, validation, and an interactive clinical decision tool.Frontiers in oncology · 2026Article
- Sarcopenic obesity in older adults: a scoping review of prevalence, assessment tools, associated factors, and interventions.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenic obesity (SO) has a higher risk of adverse health events compared to having obesity or sarcopenia alone due to the dual burden of both muscle loss and fat gain. The prevalence of SO is progressively increasing as the population ages and the obesity epidemic progresses. Currently, there are no tools for predicting the risk of SO, and this study aimed to construct a well-performing prediction tool based on machine learning.
methodsThe National Health and Nutritional Examination Surveys (NHANES) 1999-2004 dataset was used for the analysis, and the included data were randomly divided into training and validation sets in the ratio of 70:30. Missing data is processed using multiple interpolation technique. A 5-fold cross-validated recursive feature elimination algorithm is used to rank the importance of features, and the top three important features from each algorithm are used as the features of the model for constructing the machine learning model. Six machine learning methods, CART, GBM, KNN, LR, NNet, XGBoost, were used to develop models and evaluated for discrimination, calibration, clinical utility, and robustness. The combined best-performing model was further developed into an online web calculator for clinical applications.
resultsThe study had 5607 participants, and 1139 (20.3%) of them had SO, with a prevalence of 21.2% among females and 19.4% among males. Combining all the performance evaluations, the GBM-based model has the best performance, which uses age, race, and BMI as the features of the model, and its AUC values in the training and validation sets are 0.820 and 0.832, and it has good calibration, clinical utility, and robustness.
conclusionIn this study, the GBM-based model performed well, and an online web calculator constructed on the basis of the model was used to identify the risk of SO in the US community for those over the age of 60.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.